title: The challenges of comparing a clinically validated test to other methods.
authors.forename: John F
authors.initials: JF
authors.lastname: Palma
authors.forename: Felice
authors.initials: F
authors.lastname: Shieh
authors.forename: Lasse S
authors.initials: LS
authors.lastname: Kristensen
authors.forename: Lise Lotte
authors.initials: LL
authors.lastname: Hansen
authors.forename: Johanne
authors.initials: J
authors.lastname: Lade-Keller
authors.forename: Rikke
authors.initials: R
authors.lastname: Riber-Hansen
authors.forename: Torben
authors.initials: T
authors.lastname: Steiniche
authors.forename: Henrik
authors.initials: H
authors.lastname: Hager
authors.forename: Per
authors.initials: P
authors.lastname: Guldberg
mesh_terms: D004252:DNA Mutational Analysis / Q000379:methods*; D005260:Female; D006801:Humans; D008297:Male; D008545:Melanoma / Q000235:genetics*; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics*; D012878:Skin Neoplasms / Q000235:genetics*
chemical_list: D048493:Proto-Oncogene Proteins B-raf